attention deficit hyperactivity disorder
Conditions
Interventions
Treatment of Children with Methylphenidate Hydrochloride Sustained Release Tablets:none
Sponsors
People’s Hospital of Guangxi Zhuang Autonomous Region
Eligibility
Sex/Gender
All
Age
6 Years to 12 Years
Inclusion criteria
Inclusion criteria: (1)Aged from 6 to 12 year;(2)ADHD was diagnosed according to American Psychiatric Association (APA) criteria (Diagnostic and statistical manual of mental disorders, 5th edition (DSM-5);(3)Treatment with sustained-release tablets of methylphenidate hydrochloride
Exclusion criteria
Exclusion criteria: (1)Previous history of tic disorder, epilepsy, schizophrenia and other mental diseases;(2)Cranial imaging examination suggested significant organic lesions;(3)An ECG test suggested an arrhythmia;(4)Other serious physical diseases and visual or auditory diseases that affect the evaluation of cognitive function;(5)Failing to complete the SNAP-IV rating scale, WFIRS-P,WISC-CR-II, sleep disorder scale, IVA-CPT, DN: CAS test.(6)The Full Scale IQ (FSIQ) < 70 by WISC-CR-II.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Das-Naglieri Cognitive function assessment system;IVA-CPT;SNAP-IV;WFIRS-P;Children's Sleep Disorder Scale;WISC-CR-II; | — |
Countries
China
Contacts
Public ContactLing Qin
People’s Hospital of Guangxi Zhuang Autonomous Region
Outcome results
None listed